Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
1. Stephen DeNelsky appointed to HBIO's Board of Directors. 2. DeNelsky brings 30 years of healthcare financing experience. 3. Board change aims to enhance governance and financial strategy. 4. Joseph Duke highlighted DeNelsky's invaluable knowledge for HBIO’s future. 5. Strong leadership expected to drive long-term value creation.